Mobility-Enabled Compression Device for Lymphedema: Interview with CEO of Koya Medical
Koya Medical, a medtech company based in California, has developed the Dayspring active compression system for the treatment of lymphedema. The company received FDA clearance for the use of Dayspring on the upper extremities in June 2020, and just recently announced 510(k) clearance for use in the lower extremities.
Lymphedema involves impaired lymphatic drainage resulting in painful swelling, and typically occurs after surgical procedures, such as the removal of cancerous lymph nodes. At present, the condition is treated through manual manipulation of the lymph system by a healthcare professional or using a compression device. Pneumatic compression devices are typically tethered to an electrical outlet, meaning that a patient must remain in place for significant periods of time, and therefore such devices interfere with daily living.
The Dayspring compression system allows patients to move around, and it includes a rechargeable, hand-held control unit, and a breathable mesh that is worn on the affected limb. The system also includes an app that allows patients and clinicians to tailor their treatment and keep track of their progress.
Medgadget had the opportunity to speak with Andy Doraiswamy, CEO, president and founder of Koya Medical about the technology.
Conn Hastings, Medgadget: Please give us an overview of lymphedema and who it affects.